CytoPherx Seals $34M

CytoPherx Inc., a developer of anti-inflammatory therapy for acute kidney injury, has raised $34 million in funding from Early Stage Partners, ONSET Ventures and Capital Midwest Fund. The money will be used to complete clinical trials and commercialize its therapy product. CytoPherx was founded in July 2007 and is based in Ann Arbor, Michigan.

PEHUB Community

Join the 12500 members of peHUB to make connections, share your opinion, and follow your favorite authors.

Join the Community

Look Who’s Tweeting

Psst! Got any hot tips?

  • This field is for validation purposes and should be left unchanged.

PE HUB News Briefs

RSS Feed Widget

Marketplace

VCJ Headlines (subscribers only)

RSS Feed Widget

Buyouts Headlines (subscribers only)

RSS Feed Widget

Reuters VC and PE feed

RSS Feed Widget